Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief

SPR ® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc Per Protocol Analysis of Clinical Outcomes with Percutaneous 60-Day Medial Branch PNS in Chronic Low Back ...
Yahoo Finance

SPRINT® PNS System Now Covered Nationally by Aetna®

SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain · GlobeNewswire Inc. Under Aetna’s updated medical policy, ...
MobiHealthNews

SPR Therapeutics gains FDA clearance for update to its percutaneous, wearable pain relief platform

Editor's note: This article has been updated to clarify FDA classification of the Sprint Peripheral Nerve Stinulation system. Cleveland, Ohio-based SPR Therapeutics announced today that it has ...
EurekAlert!

MossRehab first in Northest to offer new stroke shoulder pain device

MossRehab in Elkins Park, Pa, one of the country's leading rehabilitation institutes, is now offering the SPRINT Peripheral Nerve Stimulation (PNS) System, a non-narcotic therapy for the relief of ...
manilatimes

Predictors of Success for 60-Day Peripheral Nerve Stimulation (PNS) Used for Treatment of Chronic Shoulder Pain: A Multi-Center Retrospective Chart Review

CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Shoulder pain is one of the most common locations of chronic pain. It impacts quality of life and has the potential to become disabling for millions of ...
Business Insider

Study of Sprint Peripheral Nerve Stimulation System Demonstrates 12 Months of Low Back Pain Relief Following 60-Day Treatment

CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding its ...
KRON4 News

SPRINT® PNS Meets Primary Endpoint of Reduction in Head Pain in First Publication of Multicenter Prospective MONARCH™ Study

CLEVELAND, May 21, 2025 (GLOBE NEWSWIRE) -- Today, SPR announced the publication of the MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Study, which evaluates the use of 60-day ...
The National Law Review

SPR Announces Eight Featured Posters and Presentations at NANS 2026

CLEVELAND, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the North American ...
WDAF-TV

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting

CLEVELAND, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the ...
The National Law Review

SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025

- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- ...
manilatimes

SPRINT® PNS System Now Covered Nationally by Aetna®

SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain CLEVELAND, March 13, 2026 (GLOBE NEWSWIRE)-- SPR®, a leading ...